Schaff LR, Mellinghoff IK (2023) Glioblastoma and other primary brain malignancies in adults: a review. JAMA 329(7):574–587

Article  PubMed  PubMed Central  Google Scholar 

Stupp R et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–96

Article  CAS  PubMed  Google Scholar 

Louis DN et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231–1251

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eckel-Passow JE et al (2015) Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med 372(26):2499–508

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Zhang Z (2020) The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol 17(8):807–821

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jackson CM, Choi J, Lim M (2019) Mechanisms of immunotherapy resistance: lessons from glioblastoma. Nat Immunol 20(9):1100–1109

Article  CAS  PubMed  Google Scholar 

Klemm F et al (2020) Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells. Cell 181(7):1643-1660.e17

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qazi MA et al (2017) Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma. Ann Oncol 28(7):1448–1456

Article  CAS  PubMed  Google Scholar 

Lin H et al (2024) Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives. J Hematol Oncol 17(1):31

Article  PubMed  PubMed Central  Google Scholar 

Nassiri F et al (2023) Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. Nat Med 29(6):1370–1378

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weathers S-P, et al (2023) CTIM-23. Safety run-in results of a phase I/II study to evaluate atezolizumab in combination with cabozantinib in patients with recurrent glioblastoma. Neuro-Oncology 25(Supplement_5): v67-v67

Reardon D, et al. (2023) CTIM-25. EO2401 peptide immunotherapy + Nivolumab +/- bevacizumab in first recurrent glioblastoma: the phase 1/2 EOGBM1-18/Rosalie study (NCT04116658). Neuro-Oncology 25(Supplement_5): v67-v68.

Forde PM et al (2022) Neoadjuvant Nivolumab plus chemotherapy in resectable lung cancer. N Engl J Med 386(21):1973–1985

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khalili N et al (2023) Radiomics for characterization of the glioma immune microenvironment. NPJ Precis Oncol 7(1):59

Article  PubMed  PubMed Central  Google Scholar 

Ravi VM et al (2022) Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma. Cancer Cell 40(6):639-655.e13

Article  CAS  PubMed  Google Scholar 

(CPTAC), N.C.I.C.P.T.A.C (2018) The clinical proteomic tumor analysis consortium glioblastoma multiforme collection (CPTAC-GBM), T.C.I. Archive

Pedano, N., et al (2016) The cancer genome Atlas low grade glioma collection (TCGA-LGG), T.C.I

Zhao Z et al (2021) Chinese glioma genome Atlas (CGGA): a comprehensive resource with functional genomic data from chinese glioma patients. Genom Proteom Bioinform 19(1):1–12

Article  CAS  Google Scholar 

Hartmann K et al (2023) Imaging genomics: data fusion in uncovering disease heritability. Trends Mol Med 29(2):141–151

Article  CAS  PubMed  Google Scholar 

Li G et al (2022) An MRI radiomics approach to predict survival and tumour-infiltrating macrophages in gliomas. Brain 145(3):1151–1161

Article  PubMed  PubMed Central  Google Scholar 

Sun Q et al (2021) Biologic pathways underlying prognostic radiomics Phenotypes from paired MRI and RNA sequencing in glioblastoma. Radiology 301(3):654–663

Article  PubMed  Google Scholar 

Hu LS et al (2017) Radiogenomics to characterize regional genetic heterogeneity in glioblastoma. Neuro Oncol 19(1):128–137

Article  PubMed  Google Scholar 

Liu X et al (2018) A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas. Neuroimage Clin 20:1070–1077

Article  PubMed  PubMed Central  Google Scholar 

Wang Z et al (2022) Prognostic value of lactate metabolism-related gene expression signature in adult primary gliomas and its impact on the tumor immune microenvironment. Front Oncol 12:1008219

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang H et al (2023) Radiomic study on preoperative multi-modal magnetic resonance images identifies IDH-mutant TERT promoter-mutant gliomas. Cancer Med 12(3):2524–2537

Article  CAS  PubMed  Google Scholar 

Ozaki R, Ninomiya Y (2023) Information criteria for detecting change-points in the Cox proportional hazards model. Biometrics 79(4):3050–3065

Article  PubMed  Google Scholar 

Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28(1):27–30

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, H., et al (2021) Tumor immunological phenotype signature-based high-throughput screening for the discovery of combination immunotherapy compounds. Sci Adv 7(4). https://doi.org/10.1126/sciadv.abd7851

Jiang P et al (2018) Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24(10):1550–1558

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li T et al (2017) TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res 77(21):e108–e110

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kersch CN et al (2024) Imaging genomics of glioma revisited: analytic methods to understand spatial and temporal heterogeneity. AJNR Am J Neuroradiol https://doi.org/10.3174/ajnr.A8148

Liu D et al (2021) Imaging-genomics in glioblastoma: combining molecular and imaging signatures. Front Oncol 11:699265

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo J et al (2024) Integrating imaging and genomic data for the discovery of distinct glioblastoma subtypes: a joint learning approach. Sci Rep 14(1):4922

Article  CAS  PubMed  PubMed Central  Google Scholar 

Halestrap AP (2013) The SLC16 gene family - structure, role and regulation in health and disease. Mol Aspects Med 34(2–3):337–49

Article  CAS  PubMed  Google Scholar 

Zhang L, Qu X, Xu Y (2024) Molecular and immunological features of TREM1 and its emergence as a prognostic indicator in glioma. Front Immunol 15:1324010

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin W et al (2021) VMP1, a novel prognostic biomarker, contributes to glioma development by regulating autophagy. J Neuroinflammation 18(1):165

Article  CAS